These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30650311)

  • 1. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
    Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
    Aqel BA; Machicao V; Rosser B; Satyanarayana R; Harnois DM; Dickson RC
    J Clin Gastroenterol; 2004 Oct; 38(9):805-9. PubMed ID: 15365410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
    Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
    Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.
    Stoelinga AEC; Tushuizen ME; van den Hout WB; Girondo MDMR; de Vries ES; Levens AD; Moes DAR; Gevers TJG; van der Meer S; Brouwer HT; de Jonge HJM; de Boer YS; Beuers UHW; van der Meer AJ; van den Berg AP; Guichelaar MMJ; Drenth JPH; van Hoek B;
    Trials; 2024 Jan; 25(1):61. PubMed ID: 38233878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis.
    Marlaka JR; Papadogiannakis N; Fischler B; Casswall TH; Beijer E; Németh A
    Acta Paediatr; 2012 Sep; 101(9):993-9. PubMed ID: 22646819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
    Andries S; Casamayou L; Sempoux C; Burlet M; Reding R; Bernard Otte J; Buts JP; Sokal E
    Transplantation; 2001 Jul; 72(2):267-72. PubMed ID: 11477351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
    Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
    J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient.
    Hurtova M; Duclos-Vallée JC; Johanet C; Emile JF; Roque-Afonso AM; Feray C; Bismuth H; Samuel D
    Liver Transpl; 2001 Jun; 7(6):556-8. PubMed ID: 11443588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide in refractory autoimmune hepatitis and autoimmune hepatitis coexisting extrahepatic autoimmune disorders.
    Xiong A; Li S; Dou X; Yao Y
    Am J Med Sci; 2024 Nov; 368(5):446-454. PubMed ID: 38876435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis.
    Larsen FS; Vainer B; Eefsen M; Bjerring PN; Adel Hansen B
    World J Gastroenterol; 2007 Jun; 13(23):3232-6. PubMed ID: 17589903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
    Ferre-Aracil C; Riveiro-Barciela M; Trapero-Marugán M; Rodríguez-Perálvarez M; Llovet LP; Téllez L; Sánchez-Torrijos Y; Díaz-Fontenla F; Salcedo-Plaza M; Álvarez-López P; de la Mata M; Londoño MC; Bañares-Cañizares R; Calleja JL
    Dig Dis Sci; 2021 Aug; 66(8):2826-2832. PubMed ID: 32860579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
    Ytting H; Larsen FS
    Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis.
    Roberts SK; Strasser SI; Nicoll AJ; Kemp W; Majeed A; Mitchell J; Stuart K; Gow P; Sood S; MacQuillan G; George J; Mitchell J; McCaughan GW;
    Scand J Gastroenterol; 2020 Nov; 55(11):1309-1317. PubMed ID: 33070650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.